Back

DAPA MODA: Dapaglifozin and cardiac remodeling in chronic heart failure

22 May 2023 (09:03 - 09:15)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials: drugs and devices Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

7 More presentations in this session

Presentation thumbnail
MetAnEnd-HF - Translational and clinical aspects of metabolic, anabolic and endothelial dysfunction in heart failure
Associate Professor C. Hage (Stockholm, SE)
Slides Video
Presentation thumbnail
DAPA-HF & DELIVER: KCCQ across the EF Spectrum
Doctor A. Bhatt (San Francisco, US)
Slides Video
Presentation thumbnail
Analysis of DELIVER and DAPA-HF using win statistics
Doctor T. Kondo (Nagoya, JP)
Slides Video
Presentation thumbnail
Stellate Ganglion block for ventricular arrythmias
Doctor M. Fudim (Durham, US)
Slides Video
Presentation thumbnail
REDUCE LAP-HF II Corvia interatrial septal device
Professor F. Gustafsson (Pleasanton, US)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials: drugs and devices
Video

The Event

Event poster

Heart Failure 2023

22 May 2023 09:03 CET
You may be interested in
thumbnail
Congress Presentation
Dapagliflozin's influence on cardiac remodeling in chronic heart failure patients
thumbnail
Congress Presentation
Dapagliflozin effect on cardiopulmonary function, reverse cardiac remodelling and biomarkers in a cohort of HFrEF patients
thumbnail
Congress Presentation
Association between dapagliflozin, cardiac biomarkers, and cardiac remodeling in patients with diabetes mellitus and heart failure: a post-hoc analysis of a randomized study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources